Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 3/20 | 0.35 |
| ▸ | NPY4R | P50391 | 10/20 | 0.35 |
| ▸ | NPY1R | P25929 | 7/20 | 0.35 |
| ▸ | NPY5R | Q15761 | 6/20 | 0.35 |
| ▸ | NPY2R | P49146 | 3/20 | 0.35 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.34 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.34 |
| ▸ | C3AR1 | Q16581 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | ACE | P12821 | 2/20 | 0.32 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL163852 | 0.97 | FOLH1 (0.36) | FOLH1NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL4572685 | 0.97 | FOLH1 (0.36) | FOLH1NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL4572687 | 0.97 | FOLH1 (0.36) | FOLH1NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL4572695 | 0.97 | FOLH1 (0.36) | FOLH1NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL638492 | 0.97 | FOLH1 (0.36) | FOLH1NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL30493180 | 0.97 | FOLH1 (0.36) | FOLH1NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL4572697 | 0.97 | FOLH1 (0.36) | FOLH1NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL30664363 | 0.95 | FOLH1 (0.36) | FOLH1NPY4RNPY1RNPY5RNPY2R | |
| Biguanide SCHEMBL28973152 | 0.93 | FOLH1 (0.34) | FOLH1NPY4RNPY1RNPY5RNPY2R | |
| Phosphoric Acid SCHEMBL29091983 | 0.92 | OTC (0.38) | FOLH1NPY4RNPY1RNPY5RNPY2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115038451-A | Multimodal compositions and methods of treatment | 阿奎斯蒂弗医疗股份有限公司 | 2022-09-09 | — | — | CN | disclosed |
| CN-115003279-A | Prodrug compositions and methods of treatment | 阿奎斯蒂弗医疗股份有限公司 | 2022-09-02 | — | — | CN | disclosed |
| CN-112955124-A | Oral film compositions and dosage forms having precise active dissolution profiles | 阿奎蒂夫疗法公司 | 2021-06-11 | — | — | CN | disclosed |
| CN-105744983-B | Device and method for sustained release of therapeutic agents of low water solubility in solubilizing agents | 纳米医学系统公司 | 2019-12-27 | — | — | CN | disclosed |